Management EfficiencyThe company has return on total asset (ROA) of (15.85) % which means that it has lost $15.85 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (55.97) % meaning that it created substantial loss on money invested by shareholders.
Entity SummaryOrgenesis Inc., a service and research company, focus on the development and manufacture of cell therapy for advanced medicinal products in the field of regenerative medicine industry. Orgenesis Inc. was founded in 2008 and is based in Germantown, Maryland. Orgenesis operates under Biotechnology classification in USA and traded on BATS Exchange. It employs 103 people.Orgenesis (ORGS) is traded on BATS Exchange in USA. It is located in MARYLAND U.S.A and employs 103 people. Orgenesis is listed under Pharmaceutical Products category by Fama And French industry classification.
Orgenesis Leadership Team
Stock Performance Indicators